Résultats de la recherche

  • Flux RSS
(1 - 20 of 50)

Pages

Opening the door for hepatitis C virus infection in genetically humanized mice
Genetically humanized mice recapitulate the entire hepatitis C virus life cycle
miR-122 - a key factor and therapeutic target in liver disease.
Toward novel immunocompetent animal models for hepatitis B virus infection
L’internalisation du virus de l’hépatite C  [Hepatitis C virus internalization]
Enfermé dehors - Traitement de l'hépatite C chronique par un inhibiteur d'entrée. [Locked outside: cure of chronic hepatitis C using an entry inhibitor]
miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo.
Hepatitis C virus entry
Host-targeting agents for prevention and treatment of chronic hepatitis C - perspectives and challenges
Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies
When one receptor closes, another opens: claudins and the hepatitis C virus E1 glycoprotein
Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection
Sésame, ouvre-toi - Régulation de l'entrée du virus de l'hépatite C dans les hépatocytes. [Open Sesame: regulation of hepatitis C virus entry into hepatocytes]
Hepatitis C virus infection and related liver disease: the quest for the best animal model
Claudins and pathogenesis of viral infection
A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
Host-targeting therapies for hepatitis C virus infection: current developments and future applications
Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry
miR-122--a key factor and therapeutic target in liver disease.

Pages

Islandora displays